Innohep 12000 Unit

Innohep 12000 Unit is a subcutaneous solution containing tinzaparin sodium, used for anticoagulation therapy. This medication helps prevent blood clots and is commonly prescribed for various conditions requiring blood thinning.

Innohep 12000 Unit is primarily used for anticoagulation, which involves thinning the blood to prevent clots. It is often prescribed for conditions like deep vein thrombosis (DVT) or pulmonary embolism (PE). Patients may also use it to prevent blood clots during surgery or other medical procedures. Tinzaparin sodium, the active ingredient, works by inhibiting certain clotting factors in the blood.

Common effects of Innohep 12000 Unit may include bruising or redness at the injection site. Some users might experience mild bleeding, such as nosebleeds or gum bleeding. It's important to monitor for any signs of unusual bleeding, as this could indicate a need for medical attention.

Innohep 12000 Unit should be handled with care, especially when administering the subcutaneous injection. It's crucial to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients with a history of bleeding disorders or those taking other blood-thinning medications should use this product with caution.

Innohep 12000 Unit may interact with other medications, particularly those that affect blood clotting. Common interactants include nonsteroidal anti-inflammatory drugs (NSAIDs), aspirin, and other anticoagulants. Alcohol consumption should also be moderated, as it can increase the risk of bleeding. Always consult a healthcare provider before starting or stopping any medications while using Innohep.